XML Financial LLC Decreases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

XML Financial LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% in the first quarter, Holdings Channel reports. The fund owned 2,895 shares of the healthcare conglomerate’s stock after selling 61 shares during the period. XML Financial LLC’s holdings in UnitedHealth Group were worth $1,516,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Palumbo Wealth Management LLC lifted its position in shares of UnitedHealth Group by 28.8% during the 1st quarter. Palumbo Wealth Management LLC now owns 7,089 shares of the healthcare conglomerate’s stock worth $3,713,000 after buying an additional 1,584 shares during the last quarter. Pursue Wealth Partners LLC purchased a new stake in shares of UnitedHealth Group during the 1st quarter worth approximately $270,000. TrueMark Investments LLC lifted its position in shares of UnitedHealth Group by 26.2% during the 1st quarter. TrueMark Investments LLC now owns 12,948 shares of the healthcare conglomerate’s stock worth $6,782,000 after buying an additional 2,688 shares during the last quarter. Flagship Harbor Advisors LLC lifted its position in shares of UnitedHealth Group by 0.7% during the 1st quarter. Flagship Harbor Advisors LLC now owns 7,187 shares of the healthcare conglomerate’s stock worth $3,764,000 after buying an additional 48 shares during the last quarter. Finally, Pennsylvania Capital Management Inc. ADV lifted its position in shares of UnitedHealth Group by 3.7% during the 1st quarter. Pennsylvania Capital Management Inc. ADV now owns 2,219 shares of the healthcare conglomerate’s stock worth $1,162,000 after buying an additional 80 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $302.04 on Monday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The stock has a market cap of $273.99 billion, a PE ratio of 12.65, a price-to-earnings-growth ratio of 1.42 and a beta of 0.45. The firm’s fifty day simple moving average is $359.15 and its 200-day simple moving average is $461.96.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same period last year, the company earned $6.91 earnings per share. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.93%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. UnitedHealth Group’s dividend payout ratio is presently 37.02%.

Wall Street Analysts Forecast Growth

UNH has been the subject of several research reports. Robert W. Baird downgraded shares of UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 price target for the company. in a research report on Wednesday, June 11th. TD Securities reiterated a “hold” rating and issued a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. KeyCorp reduced their price target on shares of UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating for the company in a research report on Monday, June 2nd. Barclays reduced their price target on shares of UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a research report on Monday, June 2nd. Finally, Truist Financial reissued a “buy” rating and issued a $360.00 price objective (down from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $427.09.

Insider Buying and Selling

In other UnitedHealth Group news, CFO John F. Rex purchased 17,175 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the acquisition, the chief financial officer now owns 203,796 shares of the company’s stock, valued at approximately $59,329,091.52. This represents a 9.20% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer now owns 10,398 shares in the company, valued at $3,171,390. This represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have purchased 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.